
Alphabet's Isomorphic Labs Raises $600M for AI-Driven Drug Discovery
Isomorphic Labs, an AI-driven drug discovery company and subsidiary of Alphabet, has secured $600 million in its first external funding round. The investment was led by Thrive Capital, with participation from GV (formerly Google Ventures) and additional backing from Alphabet. Founded in 2021 and based in London, Isomorphic Labs aims